Wall Street analysts expect that Global Medical REIT Inc (NYSE:GMRE) will post $0.20 earnings per share for the current fiscal quarter, Zacks Investment Research reports. Four analysts have provided estimates for Global Medical REIT’s earnings, with the highest EPS estimate coming in at $0.20 and the lowest estimate coming in at $0.19. Global Medical REIT reported earnings of $0.18 per share in the same quarter last year, which suggests a positive year-over-year growth rate of 11.1%. The business is expected to report its next earnings report on Tuesday, May 14th.

According to Zacks, analysts expect that Global Medical REIT will report full-year earnings of $0.84 per share for the current year, with EPS estimates ranging from $0.81 to $0.90. For the next fiscal year, analysts anticipate that the firm will report earnings of $0.96 per share, with EPS estimates ranging from $0.86 to $1.12. Zacks Investment Research’s EPS calculations are a mean average based on a survey of sell-side research firms that cover Global Medical REIT.

Global Medical REIT (NYSE:GMRE) last posted its quarterly earnings data on Thursday, March 7th. The company reported $0.31 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.21 by $0.10. Global Medical REIT had a return on equity of 6.29% and a net margin of 22.62%. The firm had revenue of $14.38 million for the quarter, compared to analysts’ expectations of $14.46 million.

A number of research analysts have recently weighed in on the company. Zacks Investment Research cut Global Medical REIT from a “buy” rating to a “hold” rating in a research report on Tuesday, March 12th. Boenning Scattergood reaffirmed a “buy” rating on shares of Global Medical REIT in a research report on Thursday, March 7th. B. Riley set a $11.00 price objective on Global Medical REIT and gave the company a “buy” rating in a research report on Friday, March 8th. Finally, Janney Montgomery Scott cut Global Medical REIT from a “buy” rating to a “neutral” rating and set a $9.03 price objective on the stock. in a research report on Wednesday, December 19th. Two analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. The company has an average rating of “Buy” and a consensus price target of $10.17.

A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. BlackRock Inc. lifted its holdings in Global Medical REIT by 3.9% in the 4th quarter. BlackRock Inc. now owns 1,059,753 shares of the company’s stock worth $9,422,000 after purchasing an additional 39,560 shares in the last quarter. Vanguard Group Inc increased its stake in Global Medical REIT by 0.9% in the 3rd quarter. Vanguard Group Inc now owns 899,741 shares of the company’s stock worth $8,475,000 after acquiring an additional 7,614 shares during the last quarter. Vanguard Group Inc. increased its stake in Global Medical REIT by 0.9% in the 3rd quarter. Vanguard Group Inc. now owns 899,741 shares of the company’s stock worth $8,475,000 after acquiring an additional 7,614 shares during the last quarter. State of New Jersey Common Pension Fund D increased its stake in Global Medical REIT by 34.2% in the 4th quarter. State of New Jersey Common Pension Fund D now owns 588,000 shares of the company’s stock worth $5,227,000 after acquiring an additional 150,000 shares during the last quarter. Finally, Man Group plc increased its stake in Global Medical REIT by 17.0% in the 3rd quarter. Man Group plc now owns 296,024 shares of the company’s stock worth $2,789,000 after acquiring an additional 43,100 shares during the last quarter. 49.70% of the stock is currently owned by institutional investors.

Shares of GMRE stock traded down $0.10 during trading hours on Friday, reaching $9.78. 1,231,421 shares of the company traded hands, compared to its average volume of 279,634. Global Medical REIT has a 12-month low of $6.34 and a 12-month high of $11.02. The company has a quick ratio of 0.09, a current ratio of 0.11 and a debt-to-equity ratio of 1.25. The stock has a market cap of $257.26 million, a P/E ratio of 12.54, a PEG ratio of 1.37 and a beta of 0.62.

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, April 10th. Investors of record on Tuesday, March 26th will be issued a $0.20 dividend. The ex-dividend date of this dividend is Monday, March 25th. This represents a $0.80 dividend on an annualized basis and a yield of 8.18%. Global Medical REIT’s dividend payout ratio is presently 102.56%.

Global Medical REIT Company Profile

Global Medical REIT, Inc operates as a development stage company that intends to develop and manage a portfolio of healthcare real estate assets and properties. The company was founded on March 18, 2011 and is headquartered in Bethesda, MD.

Read More: What is Depreciation?

Get a free copy of the Zacks research report on Global Medical REIT (GMRE)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Global Medical REIT (NYSE:GMRE)

Receive News & Ratings for Global Medical REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Medical REIT and related companies with MarketBeat.com's FREE daily email newsletter.